Parathyroid Hormone versus Bisphosphonate Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic classes of drugs for osteoporosis treatment. Bone mineral density (BMD) is an essential parameter for the evaluation of anti-osteoporotic drugs. The aim of this study was to evaluate the effects of PT...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Longxiang, Xie, Xuetao, Su, Yan, Luo, Congfeng, Zhang, Changqing, Zeng, Bingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192168/
https://www.ncbi.nlm.nih.gov/pubmed/22022584
http://dx.doi.org/10.1371/journal.pone.0026267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192168/
https://www.ncbi.nlm.nih.gov/pubmed/22022584
http://dx.doi.org/10.1371/journal.pone.0026267

Ejemplares similares